Med24
Medical Research 29. 10. 2026 • 2 min read • News Medical

ATCC selected by ARPA-H to support next-generation BioStabilization technologies

ATCC has been selected by the Advanced Research Projects Agency for Health (ARPA-H) as an affiliate to provide independent verification and validation (IV&V) for its BioStabilization Systems (BoSS) program.

ATCC selected by ARPA-H to support next-generation BioStabilization technologies

ATCC has been selected by ARPA-H to support the BioStabilization Systems (BoSS) program. The program aims to shift cell therapy storage from -196°C to room temperature. Maintaining the cold chain presents significant challenges, including substantial costs and potential product loss due to temperature excursions.

Program Objectives

Reducing reliance on the cold chain could improve affordability, simplify distribution, and increase patient access to cellular medicines. ATCC will provide independent verification and validation (IV&V) for the technologies involved.

ATCC’s Role

Under this arrangement, ATCC will furnish working cell banks and standardized benchmarks to BoSS performers. The organization will independently evaluate emerging stabilization technologies, assessing their preservation of cell quality and performance. Evaluations will focus on reproducibility, scalability, ease of use, and overall suitability. Traceability will be maintained throughout the program’s assessments.

Sponsored content

ATCC’s capabilities include authenticated biological materials, scientific expertise, quality infrastructure, and program execution capabilities. The organization’s work will provide objective data to inform ARPA-H’s comparisons of different approaches. This initiative addresses a challenge in expanding patient access to advanced medicine.

Eldar Imanverdi, senior director of Business Development, ATCC Federal Solutions, expressed pride in receiving the initial award from ARPA-H and contributing to the Scalable Solutions Office’s mission. The program represents a high-risk, high-reward research effort with the potential to deliver transformative health solutions.

Original Scientific Source
News Medical
View Original Source
Medical Disclaimer All calculations, recommendations, and interpretations provided by this tool are for informational and educational purposes only. They do not substitute professional medical advice, diagnosis, or treatment. Always consult your physician regarding any health concerns.

Recommended Medical News

All news →
Advertisement